updated 3/14/2011 12:41:31 PM ET 2011-03-14T16:41:31

FLORENCE, Ky., March 14, 2011 (GLOBE NEWSWIRE) -- Immudyne, Inc. (Pink Sheets:IMMD), the leading supplier of Yeast Beta Glucan, announced today that the Company expects to be fully reporting by the first week of April, 2011, at which time two years of audited financials will be uploaded to www.otcmarkets.com . As previously disclosed, New York based PKF LLP has been retained to conduct the audit.

Immudyne recognizes the importance of providing shareowners transparency on an ongoing basis.

About PKF LLP

PKF LLP Certified Public Accountants has a 90-year old tradition of excellence and quality client service. Since 1969, PKF has been a member of PKF International Ltd., a network of independent accounting, auditing, tax and business advisory firms with members located in over 250 cities worldwide.  It also is a member of PKF North America with members in over 80 cities in the United States. 
http://www.pkfnewyork.com/   

About Immudyne

Immudyne manufactures, distributes and sells all-natural yeast beta glucan products for immune system support.

Immudyne shares trade under the ticker symbol IMMD and the Company can be found on the web at www.immudyne.com (currently being transformed.) Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release may contain words such as "anticipates,""believes," "could," "estimates," "expects," "intends," "may," "projects," "plans," "targets" and other similar language and are considered forward-looking statements. These statements are based on management's current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.

CONTACT: Immudyne, Inc.
         Mark McLaughlin
         +1-914-714-8901
         MarkMcL@immudyne.com

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 4.91%
$30K home equity loan FICO 5.20%
$75K home equity loan FICO 4.57%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.42%
13.40%
Cash Back Cards 17.92%
17.92%
Rewards Cards 17.13%
17.12%
Source: Bankrate.com